Last reviewed · How we verify
NCT05350098
Efficacy of Plant-protein Diets in Patients With Chronic Kidney Disease
NA trial testing Plant-protein Diets in Chronic Kidney Disease Stage 5 in 40 participants. Status unknown.
30 March 2024
Quick facts
| Lead sponsor | Osaka University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 1 January 2023 |
| Primary completion | 30 March 2024 |
| Estimated completion | 30 March 2024 |
| Sites | 1 location across Japan |
Drugs / interventions tested
- Plant-protein Diets
- Control Diets
Conditions studied
- Chronic Kidney Disease Stage 5 — all drugs for Chronic Kidney Disease Stage 5 →
Sponsor
Osaka University
Who can join
20 and older, any sex, with Chronic Kidney Disease Stage 5. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate the efficacy of plant-protein diets for 12 weeks in patients with advanced chronic kidney disease.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05350098
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Kidney Disease Stage 5
Currently open trials in the same condition.
- NCT06982079 — Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Kidney Function in Advanced Chronic Kidney Disease · Phase 3 · recruiting
- NCT06799936 — A Communication-Priming Intervention to Improve Shared Decision-Making Between Older Adults With Advanced CKD and Clinic · NA · recruiting
- NCT06542016 — An Evaluation of the KCCQ Score in Predicting Cardiovascular Risk in Dialysis Patients · recruiting
- NCT05726526 — CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients · NA · recruiting
Other Osaka University trials
Trials by the same sponsor.
- NCT06924151 — Isolated Surgical Aortic Valve Replacement in Low Risk AS Patients · NA · recruiting
- NCT06826027 — TAV-in-SAV in Japanese Patients · active not recruiting
- NCT06441994 — Clinical Trial of Targeted Alpha Therapy Using [At-211]PSMA-5 for Prostate Cancer · Phase 1 · recruiting
- NCT05939661 — A Multicenter Single-arm P2 to Evaluate Safety and Efficacy of the Total Neoadjuvant Therapy for cT2 Rectal Cancer · Phase 2 · recruiting
- NCT05275946 — Targeted Alpha Therapy Using Astatine (At-211) Against Differentiated Thyroid Cancer · Phase 1 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05350098 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Osaka University
- Last refreshed: 1 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05350098.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing